3XS-27836-81566
5 vaccinations
2 coded responses
27 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 208 / MD
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Registered in v-safe
- 2021-03-31
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
-
2021-04-20
Dose 2 — Pfizer-BioNTech
- 2021-04-20
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-04-23
- 2021-04-24
- 2021-04-26
- 2021-04-29
- 2021-05-04
- 2021-05-18
- 2021-05-27
- 2021-07-20
-
2021-10-01
Dose 3 — Pfizer-BioNTech
- 2021-10-19
-
2021-10-24
Survey response — day 21, dose 3MedDRA: Arthralgia, Joint swelling, Pre-existing disease, Psoriatic arthropathy — Feeling: FairFree text: Psoriatic arthritis flare - joint pain and swelling, skin rash (pre existing condition) aMedDRA releases: 2024-11 · check-in free text available
- 2021-10-31
- 2021-11-07
- 2021-11-14
- 2022-01-02
-
2022-03-05
Dose 4 — Pfizer-BioNTech
- 2022-04-01
-
2022-09-30
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-18
-
2022-12-30
Survey response — 3 months, dose 5MedDRA: Cough, Nasal congestion, Upper-airway cough syndrome — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Stuffy nose with post nasal drip mild coughMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-03-05 | Pfizer-BioNTech | No |
| 5 | 2022-09-30 | Pfizer-BioNTech | Flu |
Free text
Release 10 — day 21, dose 3
Symptoms: Psoriatic arthritis flare - joint pain and swelling, skin rash (pre existing condition) a
Release 12 — 3 months, dose 5
Symptoms: Stuffy nose with post nasal drip mild cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Joint swelling | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Psoriatic arthropathy | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release